Jan 14, 2021 / 01:30PM GMT
Chris Brinzey - Westwicke ICR - Moderator
Good morning, everyone, and welcome to day four of the 2021 Virtual ICR Conference. My name is Chris Brinzey, and I'm a member of the Westwicke ICR life sciences team. And it's my pleasure to introduce our next presenting company, PYC Therapeutics.
To take you through the story this morning, we have Sahm Nasseri, the Chief Executive Officer of US Operations.
A quick programming note before turning it over to Sahm, I just want to remind everyone who's on the webcast. (Conference Instructions) And with that, I'll pass it to you, Sahm.
Sahm Nasseri - PYC Therapeutics Ltd - CEO of US Operations
Thanks, Chris, and hi, everybody. Thanks for joining this session on PYC Therapeutics. My name is Sahm Nasseri and I am the CEO of PYC in the US. We are a biotechnology company at the moment that is heavily based in Australia, but we are building quite broadly in the US to support multiple of our drug programs moving into clinical development.
Before I tell you a little bit more about our story, I just
PYC Therapeutics Ltd at ICR Virtual Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot